Sorrento Therapeutics, Inc.
$28.8 M
Secondary/Follow-On
Sole Book-Runner
InVivo Therapeutics Holdings Corp.
$16.1 M
Secondary/Follow-On
Sole Book-Runner
San Luis Facility Development Corporation
$26.1 M
New Issue
Aldeyra Therapeutics, Inc.
$12 M
IPO
Sole Book-Runner
Intellicheck Mobilisa, Inc.
$2.1 M
Secondary/Follow-On
Sole Book-Runner
1347 Property Insurance Holdings, Inc.
$17.4 M
IPO
Sole Book-Runner
Advaxis, Inc.
$14.1 M
Secondary/Follow-On
Sole Book-Runner
Recro Pharma, Inc.
$34.5 M
IPO
Sole Book-Runner
Ceres, Inc.
$23 M
Secondary/Follow-On
Sole Book-Runner
Semler Scientific, Inc.
$10 M
IPO
Sole Book-Runner
GlobeImmune, Inc.
$7.5 M
Private Placement
NephroGenex, Inc.
$37.2 M
IPO
Sole Book-Runner